Making sense of the complicated
Background & Brief
By combining groundbreaking exosome technology from well-renowned Oxford University and the Karolinska Institute – the home of the Nobel Prize – Evox aims to revolutionise the treatment of a broad range of severe diseases, with profound implications for human health.
Evox Therapeutics need a brand identity that represents them as a major player in the harnessing and engineering the natural delivery capabilities of extracellular vesicles to develop an entirely novel class of biotherapeutics.
Sounds complicated. Our job was to make it simple.
What We Did
I was blown away by Gary’s ability to understand very complex science and articulate it in a way that anyone could understand”.
Dr Andrew Maclean Principal Oxford Sciences Innovation
Graphic exosomes formed a visual language